Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children.
Gianotti-Crosti syndrome (GCS), a self-limiting papulovesicular acrodermatitis often associated with underlying viral infection, is mainly described in children. Nine children with GCS were evaluated with dermatologic examination and serologic tests for viral infections. Therapy was modified according to the subjective symptoms of patients, which included characteristic acrolocated papulovesicles, generalized skin eruption, and mild to severe pruritus. Results of serologic investigations revealed Epstein-Barr virus, Coxsackie A virus, parvovirus B19, and parainfluenza virus 1/2. In three children no underlying viral infection was found. Therapeutic interventions included topical clioquinol lotion 1 percent, topical application of corticosteroids, systemic antihistaminic therapy, and systemic methylprednisolone. Skin lesions resolved after 2 to 4 weeks in treated as well as in nontreated children. Although GCS in children often lacks close association with a causative viral infection, such severe infections as hepatitis B and human immunodeficiency virus must be considered. Whole-body involvement seems to correlate with severe pruritus and additional general symptoms requiring more intensive therapy.
Boeck
K
K
Department of Dermatology and Allergy Biederstein, Technical University Munich, Germany.
Mempel
M
M
Schmidt
T
T
Abeck
D
D
D000169:Acrodermatitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D012698:Serologic Tests; D016896:Treatment Outcome; D014777:Virus Diseases / Q000150:complications / Q000175:diagnosis
D003879:Dermatologic Agents